Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 26:12:609459.
doi: 10.3389/fmicb.2021.609459. eCollection 2021.

Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review

Affiliations
Review

Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review

Manoj Kumar et al. Front Microbiol. .

Abstract

The looming problem of resistance to antibiotics in microorganisms is a global health concern. The drug-resistant microorganisms originating from anthropogenic sources and commercial livestock farming have posed serious environmental and health challenges. Antibiotic-resistant genes constituting the environmental "resistome" get transferred to human and veterinary pathogens. Hence, deciphering the origin, mechanism and extreme of transfer of these genetic factors into pathogens is extremely important to develop not only the therapeutic interventions to curtail the infections, but also the strategies to avert the menace of microbial drug-resistance. Clinicians, researchers and policymakers should jointly come up to develop the strategies to prevent superfluous exposure of pathogens to antibiotics in non-clinical settings. This article highlights the present scenario of increasing antimicrobial-resistance in pathogenic bacteria and the clinical importance of unconventional or non-antibiotic therapies to thwart the infectious pathogenic microorganisms.

Keywords: alternative therapies; antibiotic resistance; drug-resistance; gene transfer; health problems.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Country wide Antibiotic consumption rate (in defined daily doses (DD) per 1000 individuals) and Drug Resistance Index (DRI) along with prevalence of antibiotic resistance in some selected countries. [Data for antibiotic consumption rate (up to 2015) and prevalence of antibiotic resistance in the selected countries are retrieved from The Center for Disease Dynamics, Economics and Policy (The Center for Disease Dynamics, 2020). Drug Resistance Index map has been created from the data derived from Klein et al. (2019)].
FIGURE 2
FIGURE 2
Factors leading to rapid development and use of antibiotics increasing antibiotic-resistance among pathogens, and the routes by which resistant pathogens enter human and animal food chain. Antibiotic-resistant bacteria from humans and animals enter water sources used for drinking or irrigation. Residual antibiotics released from industries alter the natural soil and water microbiota.
FIGURE 3
FIGURE 3
Alternative non-antibiotic strategies to prevent antimicrobial-resistant infections in animals and humans. Probiotics and phages act as microbiome-modifying therapies to defend against drug-resistant pathogens. Healthy people, healthy animals and healthy environment constitute as One Health Concept to keep environment healthy (P, prebiotics; D, designer or engineered probiotics; M, microbial metabolites; FMT, fecal microbiota transplantation).

Similar articles

Cited by

References

    1. Aguilar-Toalá J., Garcia-Varela R., Garcia H., Mata-Haro V., González-Córdova A., Vallejo-Cordoba B., et al. (2018). Postbiotics: An evolving term within the functional foods field. Trends Food Sci. Technol. 75 105–114. 10.1016/j.tifs.2018.03.009 - DOI
    1. Akiba T., Koyama K., Ishiki Y., Kimura S., Fukushima T. (1960). On the mechanism of the development of multiple drug-resistant clones of Shigella. Japan. J. Microbiol. 4 219–227. 10.1111/j.1348-0421.1960.tb00170.x - DOI - PubMed
    1. Alcayaga-Miranda F., Cuenca J., Khoury M. (2017). Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Front. Immunol. 8:339. 10.3389/fimmu.2017.00339 - DOI - PMC - PubMed
    1. Allen H. K. (2014). Antibiotic resistance gene discovery in food-producing animals. Curr. Opin. Microbiol. 19 25–29. 10.1016/j.mib.2014.06.001 - DOI - PubMed
    1. Anderson R., Higgins H., Jr., Pettinga C. (1961). Symposium: how a drug is born. Cinc. J. Med. 42 49–60.

LinkOut - more resources